ABI-6250: Clinical Trials

1 trial of ABI-6250, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1

Follow ABI-6250: new trials by email Literature Review of ABI-6250 trials Research Report on ABI-6250

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Participants With Chronic Hepatitis D Virus Infection
ABI-6250 - Chronic Hepatitis D Infection
Phase 2Not yet recruitingAssembly Biosciences802026-10-012026-08-13

Sponsors

Assembly Biosciences (1)

Countries

France (1)  ·  Georgia (1)  ·  Germany (1)  ·  Italy (1)  ·  Moldova (1)  ·  New Zealand (1)  ·  Pakistan (1)  ·  Romania (1)  ·  Spain (1)  ·  Ukraine (1)  ·  United Kingdom (1)